High plasma cortisol levels are reported in patients with metastatic breast cancer (BC) than those with early-stage disease, promote glucocorticoid receptor (GR) activity at distant metastatic sites and support cancer cell colonization (18, 19). This evidence concerns the gene NR3C1 and breast cancer.